Literature DB >> 11920963

Malignant mesothelioma in Australia, 1945-2000.

James Leigh1, Patricia Davidson, Leigh Hendrie, Dale Berry.   

Abstract

BACKGROUND: Australia has maintained a total national malignant mesothelioma case register since 1980. There has been a marked increase in the incidence of mesothelioma in the last 20 years. Currently 450-600 cases are notified annually in a population of 20 million. While the history of the Wittenoom (Western Australia) crocidolite mine and its aftermath is well known, these cases comprise only 5% of the total. This study describes the incidence of mesothelioma in Australia from 1945 to 2000.
METHODS: Using register data, time trends in mesothelioma incidence were calculated. Analyses of incidence are reported by age, sex, anatomical site, and state of notification. Associations with occupational and environmental asbestos exposure histories are described. Lung fiber content measurements were made on a subset of cases.
RESULTS: Australia has had 6,329 cases of mesothelioma from 1 January 1945 to 31 December 2000. (A further 620 cases were notified in the period from 1 January 2001 to 31 October 2001.) Annual incidence rates for Australia per million population > or = 20 years (1997) were: male, 59.8; female, 10.9; total, 35.4. Incidence rates have been continually increasing and are the highest reported national rates in the world. While Western Australia has the highest rate (1997 total rate, 52.8), most cases arise from the two most populous eastern states, New South Wales and Victoria. In 88% (male 90%, female 61%) of cases, a history of asbestos exposure was obtained. Exposures occurred in a wide variety of occupational and environmental circumstances. In 80% of cases with no history of exposure, TEM lung asbestos fiber counts > 200,000 fibers > 2 microm length per gm dry lung were obtained, suggesting unrecognized exposure.
CONCLUSIONS: Australia's high incidence of mesothelioma is related to high past asbestos use, of all fiber types, in a wide variety of occupational and environmental settings. The number of cases in total is expected to be about 18,000 by 2020, with about 11,000 yet to appear. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920963     DOI: 10.1002/ajim.10047

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  17 in total

Review 1.  Malignant pleural mesothelioma: an update on diagnosis and treatment options.

Authors:  Sanjana Kondola; David Manners; Anna K Nowak
Journal:  Ther Adv Respir Dis       Date:  2016-02-12       Impact factor: 4.031

Review 2.  Malignant mesothelioma: facts, myths, and hypotheses.

Authors:  Michele Carbone; Bevan H Ly; Ronald F Dodson; Ian Pagano; Paul T Morris; Umran A Dogan; Adi F Gazdar; Harvey I Pass; Haining Yang
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

3.  Advances in malignant pleural mesothelioma therapy: targeting EphA2 a novel approach.

Authors:  Najmunnisa Nasreen; Nazli Khodayari; Kamal A Mohammed
Journal:  Am J Cancer Res       Date:  2012-02-15       Impact factor: 6.166

Review 4.  Advances in malignant peritoneal mesothelioma.

Authors:  Shoubo Cao; Shi Jin; Jingyan Cao; Jing Shen; Jing Hu; Dehai Che; Bo Pan; Jiawen Zhang; Xiaoxi He; Dian Ding; Feifei Gu; Yan Yu
Journal:  Int J Colorectal Dis       Date:  2014-10-21       Impact factor: 2.571

5.  Changing trends in US mesothelioma incidence.

Authors:  H Weill; J M Hughes; A M Churg
Journal:  Occup Environ Med       Date:  2004-05       Impact factor: 4.402

Review 6.  Malignant pleural mesothelioma: current and future perspectives.

Authors:  Konstantinos Porpodis; Paul Zarogoulidis; Efimia Boutsikou; Antonis Papaioannou; Nikolaos Machairiotis; Kosmas Tsakiridis; Nikolaos Katsikogiannis; Bojan Zaric; Branislav Perin; Haidong Huang; Ioanna Kougioumtzi; Dionysios Spyratos; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

7.  The French National Mesothelioma Surveillance Program.

Authors:  M Goldberg; E Imbernon; P Rolland; A Gilg Soit Ilg; M Savès; A de Quillacq; C Frenay; S Chamming's; P Arveux; C Boutin; G Launoy; J C Pairon; P Astoul; F Galateau-Sallé; P Brochard
Journal:  Occup Environ Med       Date:  2006-02-09       Impact factor: 4.402

Review 8.  [Morphological diagnostics of malignant pleural mesothelioma].

Authors:  K Junker; K-M Müller
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

9.  Malignant pleural mesothelioma: an epidemiological perspective.

Authors:  Benjamin M Robinson
Journal:  Ann Cardiothorac Surg       Date:  2012-11

10.  Epidemiology of malignant mesothelioma in Italy: surveillance systems, territorial clusters and occupations involved.

Authors:  Alessandro Marinaccio; Alessandra Binazzi; Michela Bonafede; Davide Di Marzio; Alberto Scarselli
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.